The pathogenicity of Plasmodium falciparum is due largely t o the parasite's unique ability t o adhere t o capillary and postcapillary venular endothelium during the second half of the 48-hour life cycle. The resulting sequestration of infected erythrocytes (IRBC) in deep vascular beds leads t o tissue hypoxia, metabolic disturbances, and organ dysfunction which characterize severe falciparum malaria. Several endothelial receptors of cytoadherence have been identified, but their clinical relevance remains controversial. In the present report, the receptor specificity of 60 clinical P falciparum isotates was determined using transfectants each expressing one of CD36, intercellular adhesion molecule-1 (ICAM-1). E-selectin, and vascular cell adhesion molecule-1 (VCAM-1). All isolates tested adhered t o CD36 and ICAM-1, but the adherence t o CD36 was at least 10-fold higher. Seven isolates adhered t o E-selectin whereas none of 19 isolates ad-
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HE PATHOGENICITY of Plasmodium falciparum is
T due largely to the parasite's unique ability to adhere to capillary and postcapillary venular endothelium during the second half of the 48-hour life cycle, a process termed cytoadherence.' The resulting sequestration of infected erythrocytes (IRBC) in deep vascular beds leads to tissue hypoxia, metabolic disturbances, and organ dysfunction that characterize severe falciparum malaria.' In contrast to the sequestration of IRBC, there is no perivascular inflammatory infiltrate and little evidence of thrombus formation.
The stage and host cell specificity of cytoadherence suggests that the process involves specific parasite ligands, which are expressed on the surface of IRBC, and endothelial receptors. Over the past decade, great progress has been made in our understanding of the molecular events associated with cytoadherence. On the parasite side, the most significant advance is the recent cloning and sequencing of the family of var genes that encodes the cytoadherent ligand hered t o VCAM-1. From a population standpoint, about 30% of IRBC in each isolate adhered t o CD36, and 2% t o 3% adhered t o CAM-1. The percentage adherent t o E-selectin and VCAM-1 was negligible. IRBC selected on CD36 adhered almost exclusively t o CD36 whereas 80% t o 90% of IRBC selected on ICAM-1 could also adhere t o CD36. Selected IRBC did not adhere t o E-selectin or VCAM-1. These findings indicate that cytoadherence t o multiple endothelial receptors is a rare occurrence with natural P falciparum isolates, but do not exclude a role for the adhesion molecules in promoting other IRBC-endothelial interactions such as rolling under flow conditions. Receptor specificity in vivo may be dictated by the ligand-receptor combination which provides the best survivaf potential for the parasite. 0 1996 by The American Society of Hematology.
PfEMP1 ( P falciparum erythrocyte membrane protein l).'.' Members of this protein family mediate both binding to diverse endothelial receptors and antigenic variation5 which has been estimated to occur at a rate of 2.4% per cycle.' Furthermore, domains are present in PfEMPl that are similar to the extracellular domains of adhesion molecules, which suggests that the interaction between IRBC and the vascular endothelium may resemble other cell-to-cell interactions involving these types of molecules. Modified forms of the host erythrocyte anion transporter band 3 have also been implicated as cytoadherent ligands.' These cryptic antigens are exposed on the surface of IRBC as a result of conformational changes induced by the maturing P falciparum parasite. Synthetic peptides based on motifs present in band 3 protein inhibit cytoadherence in vitro and in Saimuri monkeys in vivo.* More recently, a trypsin-resistant parasite ligand which interacts with chondroitin sulfate has been de~cribed.~.'" On the endothelial cell, several receptors for IRBC have been identified using laboratory-adapted parasite lines and clones. These include the adhesion molecules CD36,' 'L" intercellular adhesion molecule-1 (ICAM-l),I4 E-selectin, and vascular cell adhesion molecule-1 (VCAM-l)." CD36, or platelet glycoprotein IV, is found on monocytes, endothelial cells, platelets, and erythroblasts. It functions as a platelet collagen receptor,16 and has been proposed as the membrane receptor for the ubiquitous adhesion protein thrombospondin." IRBC can adhere to purified thrombospondin itself,'* but it is not essential for cytoadherence."." ICAM-1 and VCAM-1 belong to the Ig superfamily of adhesion molecules. The glycoprotein ICAM-1 acts as a ligand for the leukocyte integrin LFA-I and appears to play a central role in the generation of an immune response.20 It is also widely distributed on capillary endothelium, where it has been shown to be crucial for neutrophil adhesion before transmigration of these cells into an inflammatory focus." VCAM-1 interacts with its ligand, the P I integrin VLA-4, and provides a second lymphocyte-endothelium adhesion mechanism distinct from that of LFA-1 and ICAM-1 .** Sickle retic- ulocytes also adhere to endothelium through VCAM-1 ?' Eselectin belongs to a family of differentially expressed adhesive molecules which has been shown to support the rolling of neutrophils."
The importance of each of these different endothelial receptor molecules in the cytoadherence of IRBC in vivo remains controversial, as findings from studies of clinical P falciparum isolates often do not corroborate observations made with laboratory-manipulated parasites. Thus, although laboratory parasites can be selected to adhere almost exclusively to ICAM-1,I4 previous studies on the receptor specificity of P falciparum parasites isolated directly from over 100 adult Thai patients indicated that the parasites adhered preferentially to CD36 rather than to ICAM-1 where cytoadherence was at least 10-fold l o~e r .~~.~' Furthermore, the degree of adhesion to CD36 but not to ICAM-1 correlated positively with disease severity. Adhesion to purified E-selectin and VCAM-1 proteins has been shown only for a clone of parasites derived from one of these clinical isolate^.'^ The present study was conducted to determine the relative importance of CD36, ICAM-1, E-selectin, and VCAM-1 as endothelial receptors for IRBC by examining the degree of cytoadherence of clinical parasite isolates to monolayers of stable L-cell transfectants each expressing only one putative receptor molecule. In addition, panning experiments were performed to determine the percentage of infected erythrocytes in each isolate which adhered to a particular receptor, and whether the same parasites could also adhere to more than one receptor.
MATERIALS AND METHODS

Patients.
Adult Thai patients admitted with P falciparum malaria to the Hospital for Tropical Diseases (Bangkok) and Mae Sod Provincial Hospital (Mae Sod, Thailand) were studied. P falciparum infection was diagnosed by the detection of asexual forms of the parasite in peripheral blood smears. Parasite density was determined by counting the number of asexual forms of P fakiparum per 1,000 erythrocytes or per 200 white blood cells and expressed as the number of parasites per microliter. Clinical laboratory investigations included complete blood cell counts, and measurements of plasma glucose, plasma lactate, serum electrolytes, blood urea nitrogen, serum creatinine, total bilirubin, and alanine aminotransferase. In addition, arterial blood gases and pH were determined in patients with respiratory distress.
Patients were assigned prospectively to two clinical groups based on World Health Organization criteria.*' They were considered to have severe falciparum malaria if they developed at least one of the following complications: impaired levels of consciousness (Glasgow coma score < 15), pulmonary edema, serum creatinine >250 pmoU L, total bilirubin >SO pmoVL together with hyperparasitemia of > IOO,OOO/pL or hyperparasitemia of >500,000/pL alone. Anemia was not used in this classification because of its multifactorial etiology, especially in female patients. Patients with none of the above abnormalities were considered to have uncomplicated falciparum malaria.
On admission, 5 mL of blood was taken for parasite culture before antimalarial treatment was started. Washed erythrocytes were either put into culture immediately or were cryopreserved using gly~erolyte~~ and stored in liquid nitrogen. Fresh and thawed parasites were grown for 24 to 36 hours in RPMI-1640 medium (GIBCO-BRL Life Technologies, Gaithersburg, MD) supplemented with 25 mmol/L HEPES (Sigma Co, St Louis, MO), 100 units/
Parasites.
mL of penicillin and 100 pg/mL streptomycin (Sigma), 2 mmol/L glutamine (Sigma) and 10% normal AB serum from a normal Thai donor. IRBC were procured for the cytoadherence assay when the parasites had reached the late trophozoite/early schizont stage by light microscopy. Preliminary experiments indicated that the cytoadherence of fresh and cryopreserved parasites tested during the first cycle of culture in vitro was comparable.
cDNAs encoding CD36," E-selectin;' ICAM-1;' or VCAM-122 proteins were engineered by the polymerase chain reaction and ligated into the plasmid pJFE1432,33 using the XbaI and Not1 sites. pMSDCHPRT, which expresses murine HPRT under the control of a Moloney murine leukemia virus promoter, was a gift from Dr D. Denney (Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada). Mouse LA9 cells (ATCC CCL 1.4, HPRT-, APRT-) permanently expressing one of CD36, ICAM-1, E-selectin, or VCAM-1 were constructed by cotransfecting Sal I cut pJFE14 containing the appropriate cDNA (200 pg per electroporation) and Sal I cut pMSD4-HPRT DNA ( I O pg per electroporation). For each electroporation, 1 X IO8 cells were trypsinized, washed two times in HBS-EP buffer? and resuspended in 800 pL of HBS-EP. The linearized plasmids were gently mixed with the cell suspension and electroporated in a 4 mm gap cuvette using a Bio-Rad (Richmond, CA) Gene Pulser apparatus (250 V, 960 pF settings). After incubation for 24 hours in Dulbecco's modified Eagle's medium (DMEM, GIBCO) with 10% fetal bovine serum (FBS, GIBCO), the cells were incubated in selective media containing DMEM/IO% FBS and hypoxanthine 100 pmoVL/azaserine 5.8 pmol/L (Sigma). Approximately 10 to 14 days later, single colonies of HPRT+ LA9 cells were picked using cloning cylinders and expanded. Clones were incubated for an additional 6 to 10 days in DMEM/lO% FBShypoxanthine (100 pmolk), and thereafter in DMEM/IO% FBS.
Cells from each clone were subsequently screened for expression of the appropriate surface molecule in the following manner. Transformants were detached from culture flasks using 0.5 mmoVL EDTA in Ca++, Mg++ free phosphate-buffered saline (PBS), pelleted, and resuspended in PBS/O.5 mmoVL EDTA/5% FBS/O.O5% sodium azide. Monoclonal anti-CD36 (OKM5; Ortho Diagnostics, Raritan, NJ), anti-ICAM-1 (clone 15.2; CLB, Amsterdam, The Netherlands), anti-E-selectin (clone 1.2B6; AMAC Inc, Westbrook, ME), and anti-VCAM-1 (Pharmingen, San Diego, CA) were added at a final concentration of 1:lOO. After 40 minutes, the cells were washed and resuspended in PBSIEDTAIFBSlazide containing a goat-antimouse IgG fluorescein-conjugate (Jackson Laboratories, West Grove, PA) at 1:200 dilution. Stained cells were analyzed either by UV light using a Leitz Ortholux I1 microscope or by FACSCAN (Beckton Dickinson). Clones which expressed the expected cell surface molecule were expanded for use in the cytoadherence studies.
The number of receptor molecules per transfected cell of each type was determined by flow cytometry using Quantum Simply Cellular Beads (Flow Cytometry Standards Corp, San Juan, Puerto Rico) according to the manufacturer's instructions. Briefly, confluent cultures of the transfectants were treated with 0.01% EDTA in PBS for 5 to 10 minutes at 37"C, and the detached cells were washed in 10 mL PBS. One drop of Simply Cellular microbeads with 1.34 X I@ of calibrated antibody binding sites was similarly washed. Transfected cells and microbeads in separate tubes were first stained at 4°C for 30 minutes with 10 pg/ mL of mouse monoclonal antibody (MoAb) specific to each receptor. These included OKM5 (anti-CD36; Ortho Diagnostics) and 84H10 The number of binding sites per transfected cell was then calculated using the formula:
#MESF of CelUEffective FIP Ratio
The percentage of transfectants expressing each receptor molecule was also determined. These flow cytometry studies were repeated every 4 to 6 weeks to monitor the level of expression of the receptor molecules.
Preparation of transfectant monolayers for cytoadherence studies. Ten thousand transfected L-cells in 100 pL of DMEM were plated on 15 X 15 mm Thermanox coverslips (Nunc Intermed, Roskilde, Denmark) at the bottom of the wells of a 24-well plate (How Laboratory Inc, McLean, VA). The cells were allowed to adhere for 2 hours at 37°C. 5% COz, after which 500 yL of DMEM were added to each well. For preparation of monolayers in 30 mm and 60 mm tissue culture dishes, 2 x IO5 and 4 X IO5 cells in 2 and 4 mL of medium were used. After 40 hours of culture, the monolayers were rinsed with PBS and fixed with 1% formalin for 1 hour. The fixed monolayers were rinsed twice in PBS and stored in PBS at 4°C. Although the use of fixed human umbilical vein endothelial cell monolayers remains controversial, preliminary experiments with three clinical P fakiparum isolates showed that IRBC adhered equally to fresh and fixed transfectants. These results were consistent with previous observations, which showed no difference in the cytoadherence of parasite isolates to fresh and fixed C32 melanoma cells.'5 The fixed monolayers were used for a maximum of 4 weeks. Nontransfected L-cell monolayers were prepared similarly and used as controls in each assay.
Cyroadherence assay. The assay was performed in duplicate as previously described in serum-free RPMI-1640 medium, pH7.2, at I % hematocrit, and 1% parasitemia adjusted by the addition of uninfected group 0 erythrocyte^.'^ Half a milliliter of IRBC suspension was incubated with each monolayer at 37°C and 5% CO, for I hour with gentle rocking every 15 minutes. To reduce the effect of rosette formation (discussed later) on cytoadherence, IRBC suspensions were passed through a 27-gauge needle before being added onto the monolayers. At the end of one hour, the monolayers were rinsed gently to remove unattached IRBC by sequentially dipping into 4 beakers of 50 mL of PBS. They were fixed immediately with 0.5% glutaraldehyde solution for 1 minute, rinsed with distilled water, air dried, and stained with Giemsa. The number of JRBC directly adherent to 1,OOO target L-cells on each monolayer was counted under oil immersion. The mean number of adherent IRBC for duplicate monolayers was obtained and expressed as the number of infected erythrocytes per 100 target cells. The cytoadherence assay was also performed using monolayers of CD36, ICAM-I, and E-selectin transfectants which had been preincubated with the appropriate specific MoAbs at 10 pg/mL, or a polyclonal rabbit anti-E-selectin antibody (R347) which inhibits cytoadherence to tumor necrosis factor-stimulated human umbilical vein endothelia1 cells at 1:lOO dilution (a gift from Dr C.F. Ockenhouse, Walter Reed Army lnstitute of Research, Washington, DC), for 30 minutes at 37°C.
To determine the percentage of IRBC in each Panning studies.
clinical isolate which bound to a particular receptor molecule, 1 mL of parasite suspension at 1% late trophozoite/early schizont parasitemia and 1% hematocrit was added on to a monolayer of transfectants in a 30 mm tissue culture dish. The cytoadherence assay was performed as previously described. At the end of I hour, nonadherent erythrocytes were transferred to a second monolayer of the same transfected cells and the cytoadherence assay was repeated. This process was repeated until no further IRBC bound to the transfectants. The numbers of IRBC in the initial suspension and in the last nonadherent fraction were determined by UV microscopy after staining with acridine orange. The percentage of lRBC adherent to each transfectant was determined by the following equation:
To determine if the same IRBC adhered to more than one receptor molecule, IRBC were sequentially panned on each of the four transfectants. Three milliliters of parasite suspension at 5% parasitemia and 1% hematocrit were first allowed to adhere to transfected cells expressing CD36 in a 60 mm tissue culture dish in the same manner as the cytoadherence assay. Nonadherent erythrocytes were removed by rinsing the dish several times with PBS. The adherent erythrocytes were then detached from the monolayer by vigorous pipetting with 3 mL of serum-free RPMI-1640 and the suspension was overlaid on transfected cells expressing ICAM-I . The IRBC were allowed to adhere for one hour as before. The same procedure was repeated for E-selectin and VCAM-1 transfectants using detached erythrocytes from ICAM-l and E-selectin transfectant monolayers, respectively. The number of infected erythrocytes detached from each transfectant was determined using acridine orange and UV microscopy.
Rosette formation of IRBC in the first cycle of in vitro culture was determined as previously described." Briefly, one drop of a 2.5% suspension of IRBC containing trophozoites and schizonts was mounted on a glass slide with a coverslip and examined under oil immersion by phase contrast light microscopy. Two hundred IRBC were examined. A rosette was defined as an IRBC with at least two adherent uninfected RBC. The number of IRBC forming rosettes was expressed as a percentage of the total number of IRBC counted.
Medians were compared using the Mann Whitney U test (for two samples) or the Kruskal-Wallis test (for three samples). Correlation between adherence to CD36 and ICAM-I, and between rosette formation and cytoadherence, was determined by Spearman's rank sum test. A P value of <.05 was considered statistically significant.
Rosette formation.
Statistical analysis.
RESULTS
Patients.
Sixty patients with slide-positive P falcipurum malaria were studied. All of them had acquired their infection on the Thai-Burmese border where they had travelled for occupational reasons. Twenty-nine patients had uncomplicated fakiparum malaria, whereas 3 1 had evidence of severe organ dysfunction, including 10 patients who met the criteria for cerebral malaria.
TO ensure that the L-cell transfectants were expressing similar numbers of receptor molecules, the number of specific binding sites was determined by flow cytometry. The results indicate that the four transfectants expressed between 8 X 10' and 1 X lo6 binding sites per cell with more than 90% of cells from each clonal line expressing the molecule of interest. A consistent level For personal use only. on October 22, 2017. by guest www.bloodjournal.org From of receptor molecule expression was maintained throughout the period of study.
The cytoadherence of P fakiparum isolates to monolayers of CD36, ICAM-1, Eselectin, and VCAM-1 transfectants is shown in Table l . Parasites from patients with severe and uncomplicated falciparum malaria showed the same pattem of adhesion to the receptor molecules. All of them adhered to both CD36 and ICAM-1, although the median number of IRBC which adhered to CD36 was 10-fold greater than to ICAM-1. There was significant correlation between the cytoadherence to CD36 and ICAM-1 for a given isolate (r = 0.509, P < .OOl).
IRBC from only 7 parasite isolates adhered to E-selectin, whereas none of 19 isolates tested adhered to VCAM-1. Cytoadherence to these two molecules was not increased by a 10-fold increase in parasitemia (data not shown). Nor was the absence of cytoadherence related to defective surface expression of the molecules. The E-selectin was recognized by a rabbit polyclonal antibody against human E-selectin which has previously been shown to inhibit cytoadherence to activated human umbilical vein endothelium,16 and the Eselectin and VCAM-l transfectants supported the rolling of neutrophils and adhesion of lymphocytes, respectively (Udomsangpetch and Ho, unpublished observation, August 1995). In experiments with five randomly selected parasite isolates, no adherence to transfectant monolayers which had been preincubated with the specific MoAbs was observed, confirming that the adherence to the untreated monolayers was receptor specific.
To determine the percentage of parasites in an isolate that adhered to each receptor, panning experiments were performed on monolayers of the same transfectants until no further IRBC adhered. The percentage of nonadherent IRBC was then determined. The results are shown in Table 2 . About 30% of total IRBC of each isolate adhered to CD36, and 2% to 3% of IRBC adhered to ICAM-1. No difference in percent cytoadherence to either molecule was observed between the isolates from patients with uncomplicated and severe malaria, even when IRBC from patients with cerebral malaria was analyzed as a separate clinical group ( P = .242 and .771). The percentage of IRBC adherent to E-selectin and VCAM-1 transfectants was negligible in either clinical group.
Cytoadherence to transfectants. The cytoadherence of the same parasites to multiple receptor molecules was also examined. The possibility was suggested by cloning studies in which a clone of parasites from a clinical isolate derived by sequential panning on the four receptor proteins adhered to all four molecule^.'^ Because of the poor adherence to the E-selectin and VCAM-1 transfectants of the clinical isolates, sequential panning of 6 clinical isolates was performed with only CD36 and ICAM-1 transfectants in the present study. Three of the parasite isolates P95-18, p95-37, and SA 10 adhered well to ICAM-1 in the standard cytoadherence assay whereas three others, SL 42, SL 44, and P92-2, adhered poorly. The panning results are summarized in Table 3 . For both ICAM-1 binding and nonbinding parasites, less than 5% of IRBC selected on CD36 adhered to ICAM-1. In contrast, greater than 80% of IRBC selected on ICAM-1 could also adhere to CD36. IRBC selected on either CD36 or ICAM-1 did not adhere to Eselectin or VCAM-l.
Rosette formation. Rosette formation of IRBC from the clinical P falciparum isolates showed great variation. There was no correlation between the degree of rosetting and cytoadherence to any of the receptor molecules for a given isolate. However, median % rosetting was significantly higher in patients with cerebral malaria (20, range 2-71) compared to patients with noncerebral severe falciparum malaria (8, range 1-32, P = .006) and patients with uncomplicated infection (5, range 0-21, P =. 02). 
DISCUSSION
The studies in this report addressed three issues relating to the cytoadherence of P falciparum-infected erythrocytes to various endothelial receptor molecules which have not been examined previously. First, the receptor specificity to CD36, ICAM-1, E-selectin, and VCAM-1 of clinical parasite isolates was determined using a standard static cytoadherence assay. This is an important question because results obtained with selected parasite lines and clones in the laboratory cannot be extrapolated directly to natural parasite isolates, as the cytoadherent phenotype is influenced by longterm culture in vitro37 and by the selection or cloning process itself.'* The use of soluble receptor proteins further complicates data interpretation as cell-bound receptors and soluble receptor proteins may differ in their biochemical structure and valency." Receptor specificity as determined by examination of postmortem tissues is also fraught with problem^.^" Adhesion molecules may be expressed as a consequence of cytoadherence rather than causing it to occur. For example, in ischemia-reperfusion models, ischemia itself leads to cytokine production and upregulation of E-selectin and ICAM-
The results of our present investigations provide little evidence that clinical P falciparum isolates adhered to any degree to cell-bound E-selectin or VCAM-l, even though these molecules were expressed at high levels on the transfectants. Of the two molecules that the parasites did adhere to, we confirmed that CD36 plays a major role in the cytoadherence of IRBC from all parasite isolates, whereas adherence to ICAM-1 was at least 10-fold lower. In this connection, it is important to note that CD36 acts as a receptor for both Pf EMP13.4 and the modified band 3
From a population perspective, the percentage of IRBC adherent to E-selectin and VCAM-1 was negligible. Approximately 30% of IRBC adhered to CD36 in both patient groups, while 2% to 3% of IRBC were adherent to ICAM-1. This means that over 60% of IRBC did not bind to any of the receptor molecules under our experimental conditions whereas in vivo nearly all IRBC adhere. Cytoadherence of all IRBC in vivo can be inferred from the fluctuations in parasitemia in untreated falciparum malaria, and the relative paucity of mature stages of the parasite in the peripheral blood.
There are several possible explanations for the discrepancy between the in vitro and in vivo findings. Deletion of the cytoadherent region on chromosome 9 of P falciparum during in vitro cultivation of parasites has been rep~rted.'~ Alternatively, there may be other receptors for cytoadherence such as chondroitin sulphate A which has recently been reported to support the cytoadherence of a trypsin-resistant parasite ligand to C32 melanoma cells." More importantly, receptor molecules may display synergism when they are coexpressed, which we were unable to test with our present set of L-cell transfectants. Synergism is well described in the adherence of neutrophils to postcapillary venular endothelium where P-and E-selectin promote rolling of neutrophils which then adhere to ICAM-1 . 42 In preliminary experiments using a laminar flow system, we have observed that cytoadherence to C32 melanoma cells, which constitutively expresses both CD36 and ICAM-1, is significantly higher than the sum of the cytoadherence to the CD36 and ICAM-1 transfectants, although the number of binding sites on the transfectants were at least twofold higher for each receptor molecule.
Despite an equal proportion of IRBC binding to CD36 in both patient groups, differences in the kinetics of IRBCendothelial interaction were observed. CD36-adherent IRBC from patients with severe falciparum malaria were readily removed, whereas selection of IRBC from patients with uncomplicated falcipa" malaria on CD36 required additional rounds of panning. This finding suggests that while the total number of IRBC from each isolate which adhere to CD36 may be similar, the affinity of IRBC-receptor interaction may be greater for parasites from patients with severe falciparum malaria. In the adhesion of neutrophils to vascular endothelium, it has been shown that adhesion of CDI I/CD18 to ICAM-1 can be greatly enhanced by an upregulation of affinity without an actual increase in the number of receptor molecules expressed." The affinity of cytoadherence may thus be an important determinant of parasite virulence. This phenomenon is currently being studied under laminar flow conditions in which the shear stress necessary for IRBC attachment and detachment to each receptor molecule can be readily assessed.
Further panning studies showed that IRBC from six clinical isolates selected on CD36 failed to adhere to ICAM-I to any significant degree, whereas 80% to 90% of those selected on ICAM-I also adhered to CD36. This is in contrast to the findings obtained with laboratory-adapted parasite lines and clones which adhered only to ICAM-I after several rounds of selection on HUVEC.'4.40 Because there appear to be CD36 and ICAM-1 binding domains on the parasite cytoadherent ligand PfEMPl ,3,4 the present results would indicate that the adherence of P jaiciparum to CD36 exerts selection pressure on the functional expression of this particular domain, whereas adherence to ICAM-I has no such effect on the expression of the ICAM-1 binding domain. None of the selected parasites adhered to E-selectin or VCAM-1. Collectively, these findings suggest that the cytoadherence of P ,fakiparum to multiple endothelial receptors may be a rare event in natural isolates, and calls into question the tenet that TNF-(Y enhances cytoadherence to vascular endothelium in vivo through the upregulation of adhesion molecules. l4 On the other hand, IFN-y has been shown to increase the expression of CD36 by dermal microvascular endothelial cells44 and may therefore be a more relevant cytokine with regard to cytoadherence. However, TNF-(Y through its effects on the expression of ICAM-1 , Eselectin and VCAM-l may promote other IRBC-interactions as a prerequisite for adhesion, such as the rolling of IRBC on vascular endothelium. We (Udomsangpetch and Ho, unpublished observation, August 1995) and others4s have observed IRBC rolling on ICAM-1 transfectants and umbilical vein endothelium under sheer flow conditions. Finally, rosette formation was studied in parallel with cytoadherence to the different cell surface receptors. The process has been reported to interfere with cytoadherence,"' although in our hands, inhibition of rosette formation by 
